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Abstract Rationale: In rats, 5-HT1A receptors are
present in the septal region, e.g. on cholinergic neurons
of the medial septum, where they might be a substrate for
cognitively relevant interactions between cholinergic and
serotonergic systems. Objective: The present experi-
ment assessed the effects of the stimulation of septal 5-
HT1A receptors on spatial working memory. Methods:
Stimulation of septal 5-HT1A receptors was carried out by
infusions targetting the medial septum of the 5-HT1A/5-
HT7 receptor agonist 8-hydroxy-2-(di-n-propyl-amino)-
tetralin (8-OH-DPAT; 0.5 or 4 µg). Spatial memory was
assessed in a water maze using a protocol placing
emphasis on spatial working memory. The location of
the hidden platform was changed every day and
performance was assessed on two consecutive trials each
day. Results: In comparison to vehicle injections, the
intraseptal infusion of 4 µg 8-OH-DPAT impaired
performance significantly: rats treated with 8-OH-DPAT
exhibited increased distances to reach the hidden platform
on both trials 1 and 2. Rats infused with 0.5 µg showed
similar changes that failed to be significant. Such effects
were not observed when the platform was visible.
Conclusions: These results extend those of a previous
experiment which showed that intraseptal injections of 8-
OH-DPAT impaired spatial reference memory. Based on
the characteristics of the observed deficits, it is suggested
that the 8-OH-DPAT-induced impairment, rather than
being only the result of a true alteration of working
memory, might reflect a more global cognitive deficiency
in which alteration of general memory capacities may be
biased by disrupted search strategies/exploration and/or
dysfunctions of attention.
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Introduction
The central serotonergic system contributes to cognitive
processes such as learning and memory (for review, see
Meneses 1998, 1999; Buhot et al. 2000). Among the
multiple serotonergic receptors, several lines of evidence
show that the 5-HT1A receptor subtype is implicated in
cognitive processes, and particularly in spatial learning.
For example, systemic injection of the 5-HT1A/5-HT7
receptor agonist, 8-hydroxy-2-(di-n-propyl-amino)-tetralin
(8-OH-DPAT), impairs spatial memory performance in
both the water maze (Carli et al. 1995; Riekkinen et al.
1995; Kant et al. 1996, 1998) and the radial maze (Winter
and Petty 1987). Moreover, the implication of 5-HT1A
receptors in learning and memory seems to involve an
interaction with central cholinergic mechanisms, as
suggested by several studies (Riekkinen et al. 1994,
1995; Carli et al. 1997, 1998, 1999; Bertrand et al. 2001;
Lazaris et al. 2003). Concerning this issue, the septal
region is of particular interest. This structure (i) is
implicated in memory, (ii) contains neurons that provide
the hippocampus with the major part of its cholinergic
innervation (Von Cramon and Muller 1998), (iii) is also
the target of a serotonergic innervation originating in the
raphe nuclei (Milner and Veznedaroglu 1993; Acsady et al.
1996), and (iv) shows a high density of 5-HT1A binding
sites (Pazos and Palacios 1985; Chalmers and Watson
1991), some of which are located on cholinergic neurons
(Kia et al. 1996). All these elements make the septal
region a potential neuroanatomical substrate for 5-HT1A-
mediated interactions between cholinergic and serotoner-
gic systems.
Nevertheless, the cognitive implication of the 5-HT1A
receptors of this structure is not well known. For instance,
septal injections of 8-OH-DPAT increase maternal aggres-
sive behaviour (De Almeida and Lucion 1997), influence
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anxiety (De Almeida et al. 1998; Menard and Treit 1998;
Micheau and Van Marrewijk 1999) and induce antide-
pressant-like effects (Martin et al. 1990, 1991; Schreiber
and De Vry 1993). Concerning spatial memory, we
previously showed that intraseptal injections of 8-OH-
DPAT impaired reference-memory performance in the
water maze (Bertrand et al. 2000). Our hypothesis to
account for this finding was that stimulation of 5-HT1A
receptors in the septal region might have contributed to
reduce the hippocampal cholinergic tone. Insofar as spatial
working memory may be more sensitive to hippocampal
cholinergic dysfunction than spatial reference memory, as
documented by studies using pharmacological (Wirsching
et al. 1984; Beatty and Bierley 1985; Lydon and Nakajima
1992; Varvel et al. 2001) or selective lesion approaches
(Wrenn and Wiley 1998; Lehmann et al. 2000), the present
study focused on the effects induced by injections of 8-
OH-DPAT targetting the medial septum on spatial work-
ing-memory performance in the Morris water maze.
Materials and methods
Experimental procedures
All procedures involving animals and their care were conducted in
conformity with the institutional guidelines that are in compliance
with national (council directive no. 87848, October 19, 1987,
Ministère de l’Agriculture et de la Forêt, Service Vétérinaire de la
Santé et de la Protection Animales; authorization no. 67-14 bis to H.
J., no. 67-101 to S.S. and no. 6212 to J.C.C., F.B., R.G. and C.L.
under their responsibility) and international (NIH publication, no.
86023, revised 1985) laws and policies.
Animals and design
This study was conducted on young adult Long-Evans male rats
(Centre d’Elevage R. Janvier, Le Genest St-Isle, France). They
arrived at the laboratory one week before surgery and were kept in
individual transparent Makrolon cages (42×26×15 cm) in rooms that
were maintained on a 12:12 h dark-light cycle (lights on at 0700
hours) under controlled temperature (21±1°C). The rats were housed
with ad libitum access to food and water throughout the experiment.
They were randomly allocated to one of three groups, abbreviated
CSF, DPAT0.5 and DPAT4 hereafter (see below for details).
The study was conducted in two experiments. In the first one, 27
rats (nine CSF, nine DPAT0.5, nine DPAT4) were tested using a
hidden platform, while in the second experiment, 23 other rats (nine
CSF, six DPAT0.5 and eight DPAT4) were tested with a visible
platform. Separate sets of rats were used for the hidden and visible
platform protocols because, based on our experience, we consider
six microinjections per rat a maximum as regards adverse, and thus
non specific, effects around the injection site.
Surgery
One week before behavioural testing, all rats underwent surgical
implantation of a stainless steel guide cannula (length 12 mm; outer
diameter 0.40 mm) under aseptic conditions. They were anaes-
thetised with pentobarbital (0.75 mg/kg IP; Sanofi Santé Animale,
Libourne, France). The guide cannula, targetting the MS area, was
implanted at the following stereotaxic coordinates (in mm from
bregma: A +0.8; L ±1.1; DV –5.5, with the incisor bar set at 3.3 mm
below the interaural line; according to Paxinos and Watson 1998).
The cannula was implanted with an angle of 10° from the sagittal
plane, in order to avoid any injury to the sagittal sinus. Because the
microinjector needle (outer diameter 0.28 mm) was 1 mm longer
than the guide cannula, the tip of the latter was left 1 mm above the
MS area. The guide cannula was kept in place by acrylic dental
cement tightly fixed to the skull by stainless steel screws. At the end
of surgery, a stainless steel dummy was placed in the guide cannula.
After surgery, animals were allowed to recover from anaesthesia
under a warm lamp before being replaced in the home cages.
Working memory assessment
Apparatus
Spatial working memory was assessed in a Morris water maze 1
week after surgery. The apparatus consisted of a circular pool
(diameter 160 cm; height 60 cm), half-filled with water (~21 C)
made opaque with powdered milk. A circular platform (diameter
11 cm), made of transparent plastic, was placed in the pool, 1 cm
underneath the water surface and out of view from the rat. For each
trial, the rat was released from the side of the pool, facing the wall,
and was given 60 s to reach the submerged platform. When the rat
found the platform, it was left there for 10 s before the next trial was
started. When the rat did not find the platform within 60 s, the
experimenter placed it on the platform for 10 s before the next trial
was run. Using a video-tracking system (Noldus, Wageningen, The
Netherlands), the latency to reach the platform and the distance
swum by the rat were recorded for each trial. The time spent in a
virtual thigmotaxis zone (10 cm large annulus at the border of the
pool) and the distance swum therein, as well as the time spent, the
distance swum and the number of crossings above a 30-cm diameter
virtual zone corresponding to the location of the platform on the
previous day, were also recorded and analysed.
In this testing procedure, the rats had to transfer into working
memory new incoming information that needed to be remembered
for a specific testing day during a short period of time. On the next
day, this information had become irrelevant because the platform
was placed in a new location each day. All rats were given two trials
on each day, starting from different points on the wall of the pool.
Importantly, the two daily starting points were equidistant from the
platform. The different configurations used are shown in Fig. 1.
Time-line of water-maze testing
The water-maze testing lasted for 12 days. On day 0, animals
underwent a pre-training session, during which no treatment was
given. This session consisted of two 60-s trials with a visible
platform, in order to habituate the rats to the water-maze conditions.
From day 1 to day 6, the rats underwent a Test session during which
they were injected with 8-OH-DPAT or, as a control, the vehicle.
From day 7 to day 12, the rats underwent a Control session during
which they underwent no injection prior to testing. The daily
configurations of the water maze were the same as the ones used for
the Test session. Rats from the different drug groups were tested
according to a random order that was repeated on each day of
testing. This control session was run to verify that the rats were
eventually able to perform the working-memory task in absence of
any drug treatment and also that the repeated 8-OH-DPAT injections
produced no lasting alterations of behaviour.
For the second experiment with the water-maze testing protocol
using a visible platform, the rats underwent a pre-training session,
which consisted in two 60-s trials with a visible platform, during
which no treatment was given. For the six following days, the
platform remained visible and the rats underwent a Test session
during which they were subjected to injections. The different
locations of the platform and the starting points used during this
session were the same as for the previous experiment (Fig. 1; Test
session).
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Drug and control treatments
During the Test session, the rats underwent different pharmacolo-
gical treatments. CSF rats (n=18) received an intraseptal micro-
injection of 0.5 µl sterile artificial cerebrospinal fluid (Harvard
Apparatus, Les Ulis, France). DPAT0.5 (n=15) and DPAT4 (n=17)
rats received an intraseptal microinjection of 0.5 and 4 µg 8-OH-
DPAT (Sigma Aldrich, St Quentin-Fallavier, France), respectively,
dissolved in 0.5 µl sterile artificial cerebrospinal fluid. Microinjec-
tions were performed 10 min before the first trial was started. They
were made over 1 min, and the microinjection needle was left in situ
for 1 min to allow diffusion of the drug before retraction of the
cannula. Solutions of 8-OH-DPAT were prepared freshly each day.
Histological verifications
After completion of behavioural testing, each rat was given an
overdose of sodium pentobarbital (100 mg/kg). When the rats were
deeply anaesthetised, 1 µl of methylene blue was microinjected
through the cannula. The rats were then transcardially perfused with
60 ml of phosphate-buffered 4% paraformaldehyde (pH 7.4; 4°C),
the brain was extracted, post-fixed for 4 h, transferred into a 0.1 M
phosphate-buffered 25% sucrose solution for about 36–40 h.
Coronal sections (30 µm) were cut on a freezing microtome and
collected onto gelatin-coated slides. The sections were dried at room
temperature and stained with cresyl violet for histological verifica-
tion of microinjection sites. Rats with microinjection sites located
outside the MS area were discarded from the analysis.
Statistical analyses
The different parameters measured during testing, whether with a
visible or a hidden platform, were analysed using two-way
ANOVAs, that considered the Trial (1, 2) as a within-subject factor
and the Treatment (CSF, DPAT0.5, DPAT4) as a between-subject
factor. When appropriate, two-by-two comparisons were performed
using the Newman-Keuls multiple range test. The Test session and
the Control session were analysed separately.
Results
Histology
The distribution of the injection sites in the CSF, DPAT0.5
and DPAT4 rats are shown on Fig. 2. On a rostro-caudal
axis, the injection sites extended approximately from +1.2
to 0.2 mm from bregma (according to Paxinos and Watson
1998), with 41 rats out of 50 having their injection site
Fig. 2 Histological verification. Schematic representation of the
injection sites on coronal sections through the medial septum of rats
tested either with the hidden platform (left) or with the visible one
(right); coordinates are in mm from bregma (Paxinos and Watson
1998). Each symbol represents the location of the tip of the
microinjection needle in one rat. CC corpus callosum; LS lateral
septum; LV lateral ventricle; MS medial septum; VDB vertical limb
of diagonal band of Broca
Fig. 1 Working-memory procedure. Location of the platform on
the different testing days (black circles) and of corresponding
starting points (arrows). Each configuration was used once for the
Test session (days 1–6), and once again for the Control session (days
7–12). From day 1 to 6 (Test session), or day 7 to 12 (Control
session), the starting points on trials 1 and 2 were different but
equidistant from the platform
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located between 0.7 mm and 0.48 mm from bregma.
Localization of the injection sites appeared homogenous
among the three groups. Generally, a slight gliosis was
observed in the area located immediately at the tip of the
microinjection needle, and very limited damage was
observed around the guide cannula track.
Working-memory assessment
Test session
Escape distances, latencies and swim speeds Data are
shown in Fig. 3. ANOVA of the mean escape distances
(Fig. 3A) showed significant effects of factors Treatment
[F(2,24)=4.8, P<0.05] and Trial [F(1,24)=20.3, P<0.001],
but no significant interaction between them [F(2,24)=0.8].
The Treatment effect was due to significantly impaired
performance in DPAT4 rats, the distances being signifi-
cantly increased in these rats as compared to CSF rats
(P<0.05). The Trial effect was due to a significant
improvement of the overall level of performance on trial
2 as compared to trial 1 (P<0.05).
ANOVA of the mean latencies (Fig. 3B) showed a
significant Trial effect [F(1,24)=43.6, P<0.001], but
there was neither a significant Treatment effect [F(2,24)
=1.7], nor a significant interaction between both factors [F
(2,24)=0.9]. The Trial effect was due to significant
improvement of the overall level of performance on trial
2 as compared to trial 1 (P<0.05).
ANOVA of the average swimming speeds (Fig. 3C)
showed significant Treatment [F(2,24)=5.1, P<0.05] and
Trial effects [F(1,24)=27.4, P<0.001], but the interaction
between the two factors was not significant. The Treat-
ment effect was due to the fact that DPAT0.5 and DPAT4
rats were swimming significantly faster than CSF rats
(P<0.05 in each case). The Trial effect was due to an
overall swimming speed that increased significantly from
trial 1 to trial 2.
Thigmotaxis Data are shown in Fig. 4. ANOVAs of the
mean distances swum (Fig. 4A) and of the time spent
(Fig. 4B) in the thigmotaxis zone showed a significant
Trial effect [F(1,24)=31.0 and 36.9, respectively, P<0.01],
but there was neither a significant Treatment effect [F
(2,24)=2.0 and 1.1, respectively], nor a significant inter-
action between both factors [F(2,24)=0.1 and 0.01,
respectively]. The Trial effect was due to a significant
reduction of thigmotaxis, the distance and the time spent in
the thigmotaxis zone decreasing significantly in all groups
on the second trial as compared to the first one (P<0.05 in
all cases).
Returns to the platform location on the previous day Data
are shown in Fig. 5. ANOVA of the mean distances swum
in the zone where the platform was located on the previous
day (Fig. 5A) failed to show a significant Treatment effect
[F(2,24)=1.2], but showed significant Trial [F(1,24)=9.5,
P<0.01] and interaction effects [F(2,24)=5.0, P<0.01].
The Trial effect was due to a significant decrease of the
distance swum in this virtual zone on trial 2 as compared
Fig. 3 Working memory, global performance. Mean (+SEM)
distances (A, D), latencies (B, E), and swimming speeds (C, F) to
reach the platform on trials 1 and 2 during the Test session (A, B, C)
and the Control session (D, E, F). The platform was hidden
Fig. 4 Working memory, thigmotaxis. Mean (+SEM) distances
swum (A, C) and time spent (B, D) in the thigmotaxis zone on trials
1 and 2 during the Test session (A, B) and the Control session (C,
D). The platform was hidden
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to trial 1 (P<0.05). The interaction effect can be explained
by the fact that CSF rats swam significantly less distances
in this zone on trial 2 as compared with trial 1 (P<0.01),
while the distance swum by DPAT0.5 and DPAT4 rats
remained relatively stable (linear trend analysis showed a
significant decrease from trial 1 to trial 2 only in CSF rats,
their linear trend being significantly different from that of
DPAT0.5 (P=0.016), and DPAT4 rats (P=0.008), which
did not differ significantly from each other, p=0.75). In
other words, during their first trial, CSF rats were
searching for the platform on the place where it was
located on the previous day, whereas DPAT0.5 and DPAT4
did not. However, it is noteworthy that on trial 1, the
distance swum in this zone was not significantly longer in
CSF rats as compared to both other groups.
ANOVA of the time spent in this virtual zone (Fig. 5B)
showed significant effects of factors Treatment [F(2,24)
=4.3, P<0.05], Trial [F(1,24)=16.9, P<0.001], and of the
interaction [F(2,24)=7.2, P<0.01]. The Treatment effect
was due to the fact that CSF rats spent significantly more
time in the zone where the platform was located on the
previous day as compared to DPAT0.5 rats (P<0.05), but
only tended to do so in comparison to DPAT4 rats
(P=0.06). The Trial effect was due to a significant decrease
of the time spent in this zone on trial 2 as compared to trial
1. The interaction effect can be explained as for the
distances. This explanation was confirmed by trend
analysis, the linear trend of CSF rats being significantly
different from that of DPAT0.5 (P=0.005) and DPAT4 rats
(P=0.001), which did not significantly differ from each
other (P=0.66).
ANOVA of the number of crossings on the area where
the platform was located on the previous day (Fig. 5C)
yielded a picture comparable to that found for distances:
the Trial effect was significant [F(1,24)=13.6, P<0.01] and
the interaction effect was also significant [F(2,24)=6.7,
P<0.01], but the Treatment effect was not. Regardless of
the treatment, the Trial effect was mainly due to a
significant decline of the overall number of crossings from
trial 1 to trial 2. The interaction effect can be interpreted as
previously and was confirmed by a trend analysis, the
linear trend of CSF rats being significantly different from
that of DPAT0.5 (P=0.004), and DPAT4 rats (P=0.003),
which did not significantly differ from each other
(P=0.88).
Control session
Escape distances, latencies and swim speeds Data are
shown in Fig. 3. The ANOVA of the mean escape
distances (Fig. 3D) showed significant effects of factors
Treatment [F(2,24)=3.5, P<0.05] and Trial [F(1,24)=42.5,
P<0.001], but no significant interaction [F(2,24)=0.3]. The
Treatment effect was due to significantly impaired
performance in DPAT4 rats, the distances being signifi-
cantly increased in these rats as compared to CSF rats
(P<0.05). The Trial effect was due to a significant
improvement of the overall level of performance on trial
2 as compared to trial 1.
The ANOVA of the mean latencies (Fig. 3E) showed a
significant Trial effect [F(1,24)=123.2, P<0.001], but there
was neither a significant Treatment effect [F(2,24)=0.9],
nor a significant interaction between both factors [F(2,24)
=1.0]. The Trial effect was due to significant improvement
of performance on trial 2 as compared to trial 1.
The ANOVA of the average swimming speeds (Fig. 3F)
yielded a comparable picture: only the Trial effect was
significant [F(1,24)=27.5, P<0.01], and it was due to an
overall swimming speed that increased significantly from
trial 1 to trial 2.
Thigmotaxis Data are shown in Fig. 4. ANOVA of the
mean distances swum (Fig. 4C) and of the time spent
(Fig. 4D) in the thigmotaxis zone showed a significant
Trial effect [F(1,24)=19.9 and 17.4, respectively, P<0.01],
but there was neither a significant Treatment effect [F
(2,24)=1.1 and 0.4, respectively], nor a significant inter-
action between both factors [F(2,24)=0.8 and 0.5,
respectively]. The Trial effect was due to a significant
reduction of the distance swum in the thigmotaxis zone on
trial 2 as compared to trial 1.
Returns to the platform location on the previous day Data
are shown in Fig. 5.
ANOVA of the mean distances swum (Fig. 5D), of the
time spent (Fig. 5E) and of the number of crossings on the
area where the platform was located on the previous day
(Fig. 5F) showed a significant Trial effect [F(1,24)=44.7,
Fig. 5 Working memory, re-
turns to platform’s location on
the previous day. Mean (+SEM)
distances swum to (A, D), time
spent in (B, E), and number of
crossings above the area where
the platform was located on the
previous day (C, F) on trials 1
and 2 during the Test session (A,
B, C) and the Control session
(D, E, F). The platform was
hidden
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53.1 and 43.7, respectively, P<0.01], but neither a
significant Treatment effect [F(2,24)=0.9, 1.3 and 1.2,
respectively], nor a significant interaction between both
factors [F(2,24)=0.7, 0.6 and 0.8, respectively]. The Trial
effect was due to significant improvement of the overall
level of performance on trial 2 as compared to trial 1.
Visible platform
Escape distances, latencies and swim speeds Data are
shown in Fig. 6. There was no significant Treatment [F
(2,20)<3.0], Trial [F(1,20)<2.0] or interaction effect [F
(2,20)<3.0], whether on distances swum (Fig. 6A) or
latencies (Fig. 6B) to reach the platform. The ANOVA of
the average swimming speeds (Fig. 6C) only showed a
significant Trial effect [F(1,20)=14.7, P<0.01], which was
due to a significant increase of the overall swimming
speed from trial 1 to trial 2.
Thigmotaxis Data are shown in Fig. 7. There was no
significant Treatment [F(2,20)<2.0], Trial [F(1,20)<2.0] or
interaction effect [F(2,20)<2.0], whether on distances
swum (Fig. 7A) or time spent (Fig. 7B) in the thigmotaxis
zone.
Discussion
The present results show that intraseptal microinjections of
the 5-HT1A/5-HT7 agonist 8-OH-DPAT induced a deficit
in a water-maze task assessing working memory. In
comparison to vehicle-treated rats, rats injected with 4 µg
8-OH-DPAT swam faster and exhibited increased distances
to reach the platform. Rats injected with 0.5 µg showed
similar changes that failed to be significant. Such effects
were not observed when the platform was visible. These
observations extend previous ones showing that intraseptal
injections of 8-OH-DPAT altered spatial reference memory
in the water maze (Bertrand et al. 2000).
While DPAT4 rats were clearly impaired, the overall
aspect of their impairment raises important questions: did
this impairment reflect a genuine deficit of spatial working
memory? Did it correspond to a more general deficit of
learning abilities? Was it due to a non-mnemonic effect, as
for example modification of anxiety or an indirect
sensorimotor consequence?
Sensorimotor effects
The literature is quite poor concerning motor effects of 5-
HT1A receptor activation in the septal region. However,
observations such as the impairment found in DPAT4 rats,
which appeared on distances and not on latencies,
indirectly support the hypothesis that the deficit was not
due to a sensorimotor bias. Although such a deficit pattern
may seem contradictory (but can be explained by the
increased swimming speeds), it is important to underline
that in the water maze, distances are parameters depicted
as rather insensitive to sensorimotor perturbations, in
contrast to latencies (Lindner et al. 1998). Furthermore,
and this is our principal argument, when testing was
performed with a visible platform, no impairment was
observed in rats microinjected with 8-OH-DPAT. Along
the same line, locomotor activity was not affected by
intraseptal 8-OH-DPAT microinjections in mice tested in
an elevated plus maze or an 8-arm radial maze (Micheau
and Van Marrewijk 1999). The swimming speed was
increased in treated rats. This modification is at variance
Fig. 6 Visible platform, global
performance. Mean (+SEM)
distances (A), latencies (B), and
swimming speeds (C) to reach
the platform on trials 1 and 2
during the Test session
Fig. 7 Visible platform, thig-
motaxis. Mean (+SEM) dis-
tances swum (A) and time spent
(B) in the thigmotaxis zone on
trials 1 and 2 during the Test
session
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with previous results showing that swimming speed was
not affected by intraseptal 8-OH-DPAT microinjections
(Bertrand et al. 2000). Hyperactivity was also noticed in a
microdialysis bowl after systemic injections of 8-OH-
DPAT, but this effect was not observed when 8-OH-DPAT
was retrodialysed directly into the medial septum
(Bertrand et al., unpublished observations). Still in rats,
Schreiber and De Vry (1993) interpreted the increase of
mobility observed in a forced swimming test as related to
an antidepressant effect of the drug. In view of these
somewhat conflicting data, further studies are necessary to
get a clearer idea on the locomotor effects of intraseptal 8-
OH-DPAT injections.
Effects on anxiety
As stated previously and although reported results are
controversial, intraseptal injections of 8-OH-DPAT may
influence anxiety. Micheau and Van Marrewijk (1999)
reported that intraseptal injections of 1 µg 8-OH-DPAT
tended to produce an anxiogenic-like effect in an elevated
plus maze in mice. They also provided arguments
indicating that these anxiogenic effects may facilitate
memory performance. In rats, a comparable effect was
found in females at a dose of 0.5 µg, but nothing was
observed when the dose was lower (0.2 µg) or higher
(2 µg) (De Almeida et al. 1998). Additionally, in males,
Menard and Treit (1998) found no effect in the elevated
plus maze, but an anxiolytic-like effect was observed in
the shock-probe burying test (Menard and Treit 1998). In
the present study, there was no significant difference
between 8-OH-DPAT-treated and control rats on distance
swum and time spent in the vicinity of the pool walls, a
behavioural pattern usually termed thigmotaxis and which,
among other behavioural variables, is thought to reflect
fear and anxiety in the water maze (Hodges 1996).
Nevertheless, our present data do not enable a direct
assessment of the possibility that the 8-OH-DPAT-induced
effects are originating on a modification of the anxiety
level.
Cognitive effects
Several observations in DPAT4 rats support the hypothesis
of disabilities affecting attention or exploration. For
instance, DPAT4 rats swam generally longer distances to
reach the platform on first trials than controls, while even
ignoring the platform location. Such behaviour might
reflect a deficit of non-mnemonic processes, possibly of
attention or exploration strategies. Concerning attention,
different authors suggested that spatial perturbations
induced by septal lesions may reflect deficits of attention
processes rather than a pure memory deficiency (McAlo-
nan et al. 1995; Brandner and Schenk 1998). In addition,
8-OH-DPAT administered systemically was shown to
reduce performance in tasks assessing attention processes
(Carli and Samanin 2000; Nakamura and Kurasawa 2000).
Such data provide arguments regarding the possibility that,
at the highest dose, 8-OH-DPAT has altered attention
capabilities and thereby impaired water-maze performance
on the first, and most probably also on the second trials.
Another possibility concerns the exploration strategies.
During the first trials, one optimal strategy relies on the
exploration of all possible places in the pool until finding
the platform. Indeed, within each of their first trials, rats
may remember the places already visited in order to
maximise the yield of their searching displacements. This
strategy might place a high demand on both attention and
within-trial memory. In our control rats, such a search
strategy seems to occur on the first trial of a testing day.
Indeed, during the first trial, these rats spent a longer time
on the place where the platform was located on the
previous day as compared to DPAT0.5 and DPAT4 rats.
This behaviour, which is probably not based on working
memory (the delay separating two successive sessions
being of about 24 h), suggests that normal rats (i) use a
search strategy differing from that of 8-OH-DPAT-treated
rats, and (ii) are able to remember the platform location
from one day to the next. Interestingly, it seems that the
intraseptal injections of 8-OH-DPAT has induced forget-
ting of the place where the platform was located on the
previous day. This finding is strengthened by the fact that
during the control session, when testing was continued
without prior drug injections, rats from the DPAT4 group
performed almost like controls as regards the former
location of the platform (i.e. on the previous day). Given
that 8-OH-DPAT-treated rats exhibited a capacity to
remember the location of the platform on the second
trial in the working-memory version of the test, it may be
postulated that the activation of septal 5-HT1A receptors
has compromised some aspects of information consolida-
tion after the two trials of a given day. Alternatively, it is
also possible that 8-OH-DPAT injected on the next day
right before the first trial has interfered with a retrieval
process. In other words, drug-treated rats may have found
the platform and used the information of the new platform
location during the second trial to reach it more directly,
but the strategy by which they acquired this new
information during the first trial was different from that
used by CSF rats. Thus, the retrieval process to be altered
in this case concerns the place where the platform was
located on the previous day, which CSF-treated rats seem
to remember while drug-treated rats do not. Further
experiments analysing these two possibilities, perhaps
with behavioural tests that enable a clear separation of
both memory operations seem required. However, data in
the literature suggest that systematically administered 8-
OH-DPAT impairs both operations (acquisition and reten-
tion) in a passive avoidance task (Carli et al. 1992b;
Riekkinen 1994) as well as in other tasks (Meneses and
Terron 2001). Interestingly, when injected into the septal
region, 8-OH-DPAT may impair passive avoidance con-
solidation (Lee et al. 1992), suggesting that the forgetting
of the platform location of the previous day may be the
result of interference with a consolidation process rather
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than with retrieval. Further experiments seem required to
progress on this issue.
A last point deserving discussion concerns the fact that
part of the differences between 8-OH-DPAT-treated and
CSF-treated rats were still observed during the control
session (days 7–12), when testing was continued without
drug injections. Although less pronounced than during the
drug session, these differences might reflect structural or
lasting functional alterations related to the repeated drug
injections. Upon histological verifications, evidence for
limited gliosis or weak damage around the injection site
could be found, but this gliosis or damage was also
observed in CSF-treated rats. Thus, the possibility that the
repeated drug injections have induced functional altera-
tions accounting for the negative behavioural “after-
effects” appears more conceivable. It is not possible to
propose a mechanism for these 5-HT1A receptor-mediated
consequences. However, it may be interesting to mention
that in an earlier experiment, in which rats were treated
semi-chronically with SR57746A, a neurotrophic com-
pound having 5-HT1A agonist properties (Fournier et al.
1993), it was found that cognitive performances assessed
in a water maze were still altered several weeks and even
months after drug administrations had been suspended
(Coizet, Kelche and Cassel, unpublished data).
Neural basis of the 8-OH-DPAT effect
Regarding the location of our injection sites, it cannot be
excluded that the effects we observed could be due to
diffusion of 8-OH-DPAT towards the lateral septum, a
structure located next to the medial septum, containing 5-
HT1A receptors (Pazos and Palacios 1985) and probably
implicated in spatial memory (Farber 1996). Indeed, given
the injections conditions (a volume of 0.5 µl injected at a
speed of 1 µl/min), it is highly probable that a small
amount of the drug diffused over 300–500 µm from the
injection site. One has nevertheless to keep in mind that
the maximal concentration of the drug was near the tip of
the cannula. Intraseptal 8-OH-DPAT injections were found
to impair retention of passive avoidance (Lee et al. 1992),
but knowledge about cognitive effects of such adminis-
trations remains very sparse, and nothing is described
concerning spatial memory. Previous studies found
adverse effects of systemically administered 8-OH-DPAT
on various memory tasks (Winter and Petti 1987; Carli and
Samanin 1992; Carli et al. 1995; Riekkinen et al. 1995;
Kant et al. 1996, 1998). At least, part of these negative
effects of 8-OH-DPAT seems to involve postsynaptic 5-
HT1A receptors located in the hippocampus, as (i)
intrahippocampal injections of 8-OH-DPAT impair mem-
ory performance (Carli et al. 1992a; Ohno et al. 1993;
Warburton et al. 1997), and (ii) memory impairments
induced by systemic treatment with 8-OH-DPAT can be
reversed by intrahippocampal administration of
WAY 100135, a 5-HT1A antagonist (Carli et al. 1992a).
Thus, together with a former study (Bertrand et al. 2000),
the present results suggest that activation of 5-HT1A
receptors in the septal region may also alter memory
performance.
As stated in the Introduction, some of the cholinergic
neurons of the medial septum projecting to the hippo-
campus receive serotonergic inputs from the raphe (Milner
and Veznedaroglu 1993) and express 5-HT1A receptors
(Kia et al. 1996). Moreover, 5-HT1A receptors are
negatively coupled to adenylyl cyclase (Hoyer and Martin
1997) and in vitro, inhibit the activity of, at least, dorso-
lateral septal neurons (Van den Hooff and Galvan 1992).
Therefore, regarding the critical role of the septohippo-
campal cholinergic system in memory processes (Wirsch-
ing et al. 1984; Beatty and Bierley 1985; Lydon and
Nakajima 1992; Wrenn and Wiley 1998; Lehmann et al.
2000; Varvel et al. 2001), the impairments we observed
might be related to a reduced cholinergic tone in the
hippocampus. However, it is noteworthy that even large
cholinergic lesions in the medial septum and the diagonal
band of Broca do not induce dramatic effects on working
memory in the water maze (Lehmann et al. 2002).
Furthermore, intraseptal retrodialysis of 8-OH-DPAT
failed to modify the release of acetylcholine in the
hippocampus (Bertrand et al., unpublished)
Thus, other hypotheses may be proposed. For instance,
different authors suggested that serotonergic fibres origi-
nating in the raphe nuclei and innervating the medial
septum may exert an inhibitory influence on the rhythmi-
cal firing of septal neurons (Assaf and Miller 1978;
Kinney et al. 1996; Leranth and Vertes 1999). This
rhythmical firing is thought to be one of the “pacemakers”
for the hippocampal theta rhythm (for review, see Vertes
and Kocsis 1997), and has been linked to mnesic processes
(O’Keefe 1993; Vinogradova 1995). Therefore, although
the type of serotonergic receptors involved in the seroto-
nin-mediated inhibition of medial septal neurons firing is
yet unknown, it is possible that intraseptal injections of 8-
OH-DPAT interacted with the rhythmical firing of septal
neurons, leading to desynchronisation of hippocampal
activity, and thus to memory disturbance or to a more
general disorganisation of behaviour in the water maze.
A role for GABAergic neurons, which are modulated by
serotonin, is also possible (Alreja 1996). Further studies,
perhaps relying upon electrophysiological techniques and
taxing cholinergic and GABAergic neurotransmission
characteristics after an intraseptal injection of 8-OH-
DAPT seem to be required to analyse these issues.
In conclusion, the present study shows that the stimu-
lation of 5-HT1A receptors in the septal region of rats by
local injections of 8-OH-DPAT induces a complex, in
some respects dose-dependent, pattern of deficits in a
water-maze task designed to assess spatial working
memory. Based on the characteristics of the observed
deficits, it is suggested that the 8-OH-DPAT-induced
impairment, rather than being only the result of a true
alteration of working memory, might reflect a more global
cognitive deficiency in which perturbations of general
memory capacities may be mixed with attention dysfunc-
tions, alterations of search strategies or modification of
anxiety. Future studies should help to clarify this issue by
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using tests that measure these different aspects of cogni-
tion more selectively, but one may suggest that activation
of 5-HT1A/5HT7 receptors in the septal region results in
alteration of the organisation of behaviour requiring a
cognitive investment.
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